Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-27
2009-02-03
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S132000
Reexamination Certificate
active
07485650
ABSTRACT:
The compound of the formulaor a pharmaceutically acceptable salt or solvate thereof, pharmaceutical compositions therefore, and the use of said compounds as nociceptin receptor inhibitors useful in the treatment of anxiety are disclosed.
REFERENCES:
patent: 6262066 (2001-07-01), Tulshian et al.
patent: 7094784 (2006-08-01), Tulshian et al.
patent: 2001/0011092 (2001-08-01), Tulshian et al.
patent: 2006/0217414 (2006-09-01), Sawutz et al.
PCT International Search Report for PCT/US2006/041714 dated Mar. 22, 2007.
Bercovici Ana
Brianceau Philippe
Ho Ginny D.
Sawutz David G.
Tulshian Deen
Banerjee Krishna G.
Rao Deepak
Schering Corporation
LandOfFree
High affinity ligands for nociceptin receptor ORL-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High affinity ligands for nociceptin receptor ORL-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High affinity ligands for nociceptin receptor ORL-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107301